Following the promising results of a small pilot study, senior living provider Ecumen said it will be incorporating light therapy into a care program that emphasizes managing dementia without highly sedating...
Research focuses on diagnosing, lessening effects of Alzheimer’s disease
By
Kimberly Bonvissuto
Jun 28, 2022
More than 6 million Americans are living with Alzheimer’s disease, costing the nation $321 billion in 2022, according to the Alzheimer’s Association. A variety of studies and pilot programs are underway...
Cranberry supplements may aid memory in older adults
May 24, 2022
Improvement in neural functioning also was seen during a 12-week intervention.
Road traffic, railway noise linked to increased dementia risk
Sep 10, 2021
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Wisconsin: Dementia bills pass committees
Feb 07, 2016
Wisconsin lawmakers are considering 10 bills designed to aid those with dementia, although senior living groups oppose one of the measures.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
Spotlight on smart lock highlights ways families, senior caregivers can keep those with dementia safe
By
Aaron Dorman
Sep 11, 2023
A smart lock for dementia highlights recent tech aimed at monitoring and keeping senior family members safe.
Changing perceptions of aging through art
By
Lois A. Bowers
Dec 01, 2016
MacArthur Fellow Anne Basting discusses her plans to change perceptions related to aging.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.